Tryton Medical has announced that it will be sponsoring a clinical symposium and exhibiting at the 2016 Transcatheter Cardiovascular Therapeutics (TCT) meeting (29 October–2 November, Washington, DC, USA). The symposium is entitled “Establishing the New Standard: Definitive Treatment for Complex Bifurcation Lesions,” will be held in Room 143B on 31 October from 6:30am to 8am.
Martin Leon (director of the Center for Interventional Vascular Therapy, New York-Presbyterian Hospital/Columbia University in New York City, USA) and David Rizik (interventional cardiologist at HonorHealth Heart Group in Scottsdale, USA) will serve as chairmen of the symposium. They along with the faculty (which includes Philippe Généreux, Columbia University Medical Center/Hôpital du Sacré-Coeur de Montréal and others) will discuss how the Tryton Side Branch Stent might change daily practice after reviewing results from safety and efficacy studies.
The symposium will also feature a presentation on the importance of side branch ostial scaffolding in bifurcation lesions involving large side branches (≥2.5mm), and an EU perspective on left main coronary artery disease.
Shawn McCarthy, president and chief executive officer of Tryton Medical, says: “This symposium presents an exciting opportunity to learn about treating bifurcation lesions from leading interventionists from around the world. The faculty will highlight the significant need for technologies and strategies to achieve more consistent outcomes for bifurcated lesions, particularly when a large side branch is involved. We look forward to a discussion on how the Tryton Side Branch Stent is designed to support complete lesion coverage with a more predictable procedure.”
Tryton will also exhibit at booth 1343 at TCT 2016.
